Table 2.
Oligonucleotides used in this study.
| Target | Name and Sequence (5’ ➔ 3’) | Size (bp) |
|---|---|---|
| Cloning and Sequencing Primers | ||
| plzA |
plzA F: GGCAGCCATATGCTTTTATCTAGAAAAATAAGAGATTATG plzA R: GTGGTGCTCGAGTTAATTGAAATAATCATGGATCAAC |
786 |
| MCS pET28a(+):plzA | T7 F: TAATACGACTCACTATAGGGT7 R: TAGTTATTGCTCAGCGGTGG |
1026 |
| pCR 2.1 TA clones | M13 F: GTAAAACGACGGCCAG M13 R: CAGGAAACAGCTATGAC |
N/A |
| plzA-NTD |
plzA 1F: ATGCTTTTATCTAGAAAAATAAGAGATTATG plzA N R: TTACTGATTTTGCCCAAGCTTTAAATC |
435 |
| plzA-CTD |
plzA C F: ATGGATTTAAAGCTTGGGCAA plzA 1R: ATTGAAATAATCATGGATCAACATAGTATAC |
378 |
| Site-directed Mutagenesis Primers | ||
| plzA R145-149D |
plzA-mut F: AATCAGGACATTCATGAGGACATTATTATCGATAAAGATTCTATTAG plzA-mut R: GTCCTCATGAATGTCCTGATTTTGCCCAAGCTTTAAATCAAGAAGCTTTCC |
786 |
| EMSA Probes, Competitors, and Primers | ||
| glpFKD(−219) | M13 F: GTAAAACGACGGCCAG M13 R 5’IRD800CW or unlabeled: CAGGAAACAGCTATGAC |
654 |
| glpFKD(−7/+35) |
glpF F IRD800: ATTAAATATAATTTTAATAAGGCTTTTATTAGAAAAATTAAT glpF R: ATTAATTTTTCTAATAAAAGCCTTATTAAAATTATATTTAAT |
42 |
| ssglpF |
glpF F IRD800: ATTAAATATAATTTTAATAAGGCTTTTATTAGAAAAATTAAT |
42 |
| glpFKD(UTR) RNA |
glpF RNA 5’ Alexa488: AUAAUUUUAAUAAGGCUUUUAUUAGAAAAAUUAAU |
35 |
| pCR 2.1 competitor | M13 F: GTAAAACGACGGCCAG M13 R: CAGGAAACAGCTATGAC |
210 |
Bolded and underlined nucleotides indicate restriction enzyme sites.